Immune dysregulation in multiple myeloma: the current and future role of cell-based immunotherapy

Immune dysregulation is a hallmark of clinically active multiple myeloma (MM). Interactions between malignant clonal cells and immune cells within the bone marrow microenvironment are associated with the formation of a milieu favorable to tumor progression. IL-10, TGF-β and other immunoregulatory pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Russell, Brian M., Avigan, David E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Progress in Hematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039687/
https://www.ncbi.nlm.nih.gov/pubmed/36964840
http://dx.doi.org/10.1007/s12185-023-03579-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039687/
https://www.ncbi.nlm.nih.gov/pubmed/36964840
http://dx.doi.org/10.1007/s12185-023-03579-x

Ejemplares similares